Pharma Stocks In Focus: Why Indian Healthcare Could Deliver Strong Growth Over 6–12 Months

Pharma and healthcare are emerging as key sectors to watch, with multiple growth drivers supporting the industry. Sudip Bandyopadhyay, Market Expert, believes Indian pharma is approaching a major transformation, similar to where Indian IT stood two decades ago. Large companies are moving towards branded and patented products, while CDMO players are benefiting from the China-plus-one strategy as global pharma companies increase sourcing from India. Domestic-focused pharma companies are also seeing strong growth, supported by rising demand. Although valuations are not particularly cheap, the sector offers attractive long-term growth potential. Investors are increasingly looking at pharma as a key opportunity.